Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity - sprookjes - yvandenbroek - TriplyDB

Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity

Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity

http://www.wikidata.org/entity/Q28546110

about

A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future Perspectives Can Relative Binding Free Energy Predict Selectivity of Reversible Covalent Inhibitors?

P2860

Q26739015-00173BAB-C835-42B3-A1D2-62FD5C5DC60F Q45934140-1FDC143F-2D56-484C-ABDB-4063D3392B97

P2860

Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity

http://www.wikidata.org/entity/Q28546110

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@ast

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@en

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@nl

type

label

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@ast

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@en

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@nl

prefLabel

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@ast

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@en

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@nl

P1433

Q28546110-C45CFE80-E2FF-45B5-B039-49963C9DF27E

P1476

Q28546110-86965FE2-F4B8-4AD6-86CD-6E0BE4924460

P2093

Q28546110-27C229AA-932F-4C66-84A4-789EDB94394F

Q28546110-2B97ABC7-96C4-4DA2-9297-AC1C0AE34D16

Q28546110-50DF80E0-85B5-406E-AC09-E92DCC7DFA33

Q28546110-9626F9B3-BDA2-4810-BBC2-A26EFCA68C92

Q28546110-F6F85399-8017-4631-B4C9-B56A7474D169

P2860

Q28546110-0EC142C9-3566-481A-964E-32F36065AD9B

Q28546110-11D9B5C9-5657-496E-9AC6-B69E834E68D8

Q28546110-1554E1E8-695C-40E0-8DE7-8E1FE0AFB471

Q28546110-1B2F6AE3-BABA-4D79-8824-4240A996FEC0

Q28546110-1FBCF823-D010-4ED8-9567-C8356B9F32CA

Q28546110-2072ADD1-75E4-4EB9-9EAE-5EB33E976E68

Q28546110-21481489-392E-4BB5-9460-1C75052CF133

Q28546110-290DA509-42CB-413F-A5D4-4648DCF1D3A5

Q28546110-2E964EA4-5317-4573-90EF-5CFAF6D71FD2

Q28546110-30B21E84-6842-4C85-805D-1EB954C44594

P304

Q28546110-5A30148E-5C6C-41F4-AA03-620BCC5E5B3B

P31

Q28546110-A10749DE-64D7-49A2-856C-B24FC1E5A7C9

P3181

Q28546110-A2E0E969-9C77-4474-B2F2-FE54033CF244

P356

Q28546110-8DD9CD79-6B50-40FC-B4C5-D5D410E58B74

P407

Q28546110-30641340-6DE9-4CA0-86DF-BD8DDAE2DBBA

P433

Q28546110-045CA159-E834-44B8-BD8F-3F3847125663

P478

Q28546110-4ACA6009-D29B-4002-AF98-AFFEED20F2E7

P577

Q28546110-1FA0D284-39AE-419C-A3B8-F42264241BDA

P5875

Q28546110-BC9C6D5C-03FC-4070-B272-B5B6116BCF6D

P698

Q28546110-DC16A84B-B482-41AE-81AA-CA88F4D3623B

P921

Q28546110-072E8FBF-0930-4379-823C-105B8CE719F2

Q28546110-20580BCE-4DBC-44C0-8A80-081F2B5ADD31

P932

Q28546110-C42A654D-38D8-4F74-AAD4-5EA7771522B3

P3181

P356

JOURNAL.PONE.0132221

P1433

P1476

Uncovering Molecular Bases Und ...... Receptor Inhibitor Selectivity

@en

P2093

Abdelaziz Alsamarah

http://www.w3.org/2001/XMLSchema#string

Alecander E LaCuran

http://www.w3.org/2001/XMLSchema#string

Jijun Hao

http://www.w3.org/2001/XMLSchema#string

Peter Oelschlaeger

http://www.w3.org/2001/XMLSchema#string

Yun Luo

http://www.w3.org/2001/XMLSchema#string

P2860

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

BMP type I receptor inhibition reduces heterotopic [corrected] ossification

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva

CHARMM: the biomolecular simulation program

Comparison of simple potential functions for simulating liquid water

The TGF beta receptor activation process: an inhibitor- to substrate-binding switch

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor

Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors

Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5)

Design, synthesis, and evaluation of indolinones as inhibitors of the transforming growth factor β receptor I (TGFβRI)

P304

e0132221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

464094

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0132221

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281213956

http://www.w3.org/2001/XMLSchema#string

P698

26133550

http://www.w3.org/2001/XMLSchema#string

P921

P932

4489870

http://www.w3.org/2001/XMLSchema#string